Investors are frustrated with Botox-maker Allergan - and its...

Investors are frustrated with Botox-maker Allergan - and its...

Investors are frustrated with Botox-maker Allergan - and its CEO says it's 'deep into the process' of figuring out what to do next Allergan said Monday during its first-quarter earnings call that it's "deep into the process" of its strategic review of the company amid its stock price slipping over the past year.

from Biotech News